...
首页> 外文期刊>Journal of Alzheimer's disease: JAD >Phenotypic profile of early-onset familial Alzheimer's disease caused by presenilin-1 E280A mutation
【24h】

Phenotypic profile of early-onset familial Alzheimer's disease caused by presenilin-1 E280A mutation

机译:早老素-1 E280A突变引起的家族性早老性阿尔茨海默氏病的表型特征

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Presenilin 1 (PS1) mutations are the most common cause of early-onset familial Alzheimer's disease (EOFAD). They show a common phenotypic profile characterized by early age of onset, severe dementia and distinct neurodegeneration. The largest population of EOFAD carries the E280A mutation in PS1 and resides in Antioquia, Colombia, currently comprising around 5,000 individuals. Carriers start showing memory impairment in the third decade of life, followed by progressive impairment of language and other cognitive processes. They reach mild cognitive impairment around 45 and dementia around 50 years of age. There is some phenotypic variability among the carriers of this single PS1 mutation. Some patients present with epilepsy, verbal impairment, and cerebellar ataxia. Neuropathologically, PS1 E280A cases show pronounced brain atrophy, severe amyloid-β pathology, distinct hyperphosphorylated tau-related pathology, and cerebellar damage. The earliest event identified by functional magnetic imaging resonance is hyperactivation within the right anterior hippocampus around 33 years of age. This well-studied population with a clear pre-clinical profile and wide phenotypic variability in age of onset and clinical presentation is ideally suited for clinical trials and to study molecular mechanisms of Alzheimer's disease.
机译:早老素1(PS1)突变是早发家族性阿尔茨海默氏病(EOFAD)的最常见原因。它们显示出常见的表型特征,其特征在于发病年龄早,严重的痴呆和明显的神经变性。 EOFAD的最大人口在PS1中携带E280A突变,居住在哥伦比亚的Antioquia,目前约有5,000人。携带者在生命的第三个十年开始显示出记忆障碍,随后是语言和其他认知过程的逐步障碍。他们在45岁左右达到轻度认知障碍,在50岁左右达到痴呆。在此单个PS1突变的携带者之间存在某些表型变异性。一些患者出现癫痫,语言障碍和小脑共济失调。在神经病理学上,PS1 E280A病例表现出明显的脑萎缩,严重的淀粉样β病理,明显的磷酸化tau相关病理以及小脑损伤。通过功能性磁共振成像识别的最早事件是33岁左右的右前海马体内的过度激活。这个经过充分研究的人群具有明确的临床前特征和广泛的表型变异,发病年龄和临床表现均非常适合临床试验和研究阿尔茨海默氏病的分子机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号